The antimicrobial effect of colistin methanesulfonate on Mycobacterium tuberculosis in vitro

Loading...
Thumbnail Image

Authors

Van Breda, Shane Vontelin
Buys, Antoinette
Apostolides, Zeno
Nardell, Edward Anthony
Stoltz, Anton Carel

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

Polymyxins have previously been described to have activity against M. tuberculosis (MTB), but further research was abandoned due to systemic toxicity concerns to achieve the required MIC. Colistin methanesulfonate (CMS), a polymyxin, is well tolerated when inhaled directly into the lungs, resulting in high local concentrations. We report here for the first time, MIC and MBC data for CMS determined by the microtiter Alamar Blue assay (MABA). We also determined how the MIC would be affected by the presence of pulmonary surfactant (PS) and if any synergy with isoniazid (INH) and rifampicin (RIF) exists. The effect of CMS on the ultrastructure of MTB was also determined. The MIC for CMS was 16 mg/L, while the MBC was 256 mg/L. MIC for CMS in PS was antagonised by eight fold. For synergy, indifference was determined while time-kill assays revealed a greater killing effect when CMS was used together with INH. Ultrastructure analysis suggests that the disruption of the outer polysaccharide layer of MTB by CMS may lead to enhanced uptake of INH. Our findings may provide insight for further investigations of CMS against MTB.

Description

Keywords

Colistin methanesulfonate, Colistin sulfate, Polymyxin, Selfpromoted uptake, Tuberculosis (TB), Mycobacterium tuberculosis (MTB)

Sustainable Development Goals

Citation

Van Breda, SV, Buys, A, Apostolides, Z, Nardell, EA & Stoltz, AC 2015, 'The antimicrobial effect of colistin methanesulfonate on Mycobacterium tuberculosis in vitro', Tuberculosis, vol. 95, no. 4, pp. 440-446.